Daktari Accepted into WHO Prequalification of Diagnostics Programme
CAMBRIDGE, Mass., July 18, 2014 /PRNewswire/ -- Daktari Diagnostics is pleased to announce the acceptance of the Daktari CD4 Instrument into the Prequalification of Diagnostics Programme within the World Health Organization (WHO). The Daktari CD4 is a portable and wirelessly connected point-of-care diagnostic platform that can deliver a patient's CD4 cell count in less than 15 minutes, all from a single drop of blood.
The Daktari CD4 is geared toward resource-limited settings and is the first of Daktari's point-of-care technologies to enter the commercialization phase.
Facilitated through the Diagnostics and Laboratory Technology Team (DLT) within the department of Essential Health Technologies (EHT), the goal of the WHO Prequalification of Diagnostics program is to encourage and simplify access to safe, inexpensive, and high quality diagnostic devices intended to address the most pressing global diseases. As part of the WHO Prequalification of Diagnostics Programme, the Daktari CD4 will undergo extensive and thorough evaluation in hopes of receiving prequalification status of diagnostics. If approved, the Daktari CD4 will be eligible for procurement in United Nations' tenders.
"We are thrilled that the Daktari CD4 has been accepted into the WHO Prequalification of Diagnostics Programme," said Betsy Wonderly, Daktari's Global Product Manager. "Our team has been working incredibly hard day in and day out to bring the Daktari CD4 to those who need it the most, and being a part of the Prequalification of Diagnostics Programme is a big step forward in achieving that goal."
About WHO
WHO is the primary authority for health as part of the United Nations, where its main focus is to offer guidance and direction on global health issues by developing the health research agenda, declaring global health benchmarks, communicating policy options, delivering support to countries and keeping up with global health trends. WHO is governed by The World Health Assembly, which is made up of representatives from 194 Member States. The World Health Assembly meets once each year in Geneva to discuss and solidify guidelines.
About Daktari
Daktari Diagnostics, Inc. (www.daktaridx.com) is a venture-backed company based in Cambridge, USA. Daktari's corporate mission is to address the world's biggest health problems by building a market-leading business around a fleet of accurate, portable diagnostic products that can be deployed anywhere in the world. The Daktari technology platform combines electrochemical sensing with microfluidics, enabling highly accurate, low-cost diagnostics in a handheld format. The Daktari connectivity platform provides seamless data management for results produced at any health facility.
Media Contact
Betsy Wonderly
Daktari Diagnostics
[email protected]
+1 (617) 336-3299
Photo - http://photos.prnewswire.com/prnh/20140325/NE90169-a
Logo - http://photos.prnewswire.com/prnh/20140325/NE90169LOGO-b
SOURCE Daktari Diagnostics, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article